Showing results (1-10 of 12) with videos related to
Sort By:
Pageof 2
Neuroscience Letters|July 26, 1996
Prolonged antagonism of morphine-induced locomotor stimulation by kappa opioid agonists: enhancement by prior morphine exposureS M Pearl, S D GlickPsychopharmacology|October 1, 1995
Prior morphine exposure enhances ibogaine antagonism of morphine-induced locomotor stimulationS M Pearl, D W Johnson, S D GlickNeuropharmacology|January 1, 1996
Prior morphine exposure enhances ibogaine antagonism of morphine-induced dopamine release in ratsS M Pearl, I M Maisonneuve, S D GlickBrain Research|February 28, 1997
Evidence for roles of kappa-opioid and NMDA receptors in the mechanism of action of ibogaineS D Glick, I M Maisonneuve, S M PearlLife Sciences|January 1, 1996
Tissue distribution of ibogaine after intraperitoneal and subcutaneous administrationL B Hough, S M Pearl, S D GlickAmerican Journal of Optometry and Physiological Optics|January 1, 1987
Biofeedback training of visual acuity and myopia: a pilot studyM Gallaway, S M Pearl, A M Winkelstein, et al.Neuroscience|February 23, 2000
Inhibitory glutamatergic regulation of evoked dopamine release in striatumY Wu, S M Pearl, M J Zigmond, et al.Brain Research|March 25, 1996
Ibogaine-like effects of noribogaine in ratsS D Glick, S M Pearl, J Cai, et al.Brain Research|March 27, 1995
Radioligand-binding study of noribogaine, a likely metabolite of ibogaineS M Pearl, K Herrick-Davis, M Teitler, et al.Pharmacology, Biochemistry, and Behavior|August 1, 1997
Sex differences in ibogaine antagonism of morphine-induced locomotor activity and in ibogaine brain levels and metabolismS M Pearl, L B Hough, D L Boyd, et al.Pageof 2